Heart Valve Repair

Corevalve, VIV, valve in valve, FDA

The U.S. Food and Drug Administration (FDA) expanded the approved use of the CoreValve self-expanding transcatheter aortic valve replacement (TAVR) system to treat certain patients who have previously had a tissue aortic valve replacement and are...

he Sapien 3 heart valve (Edwards Lifesciences) demonstrated lower death, stroke and paravalvular leak rates than earlier generation devices in patients at high risk for surgery and showed encouraging results in intermediate-risk patients, accordin...

Corevalve, ACC.15

Medtronic plc unveiled new two-year data from the CoreValve U.S. Pivotal High Risk Study, which demonstrated superior two-year survival benefits from transcatheter aortic valve replacement (TAVR) with the CoreValve System compared to surgical aort...

Sapien, edwards, ACC 2015, Partner trial, TAVR

Five-year data suggest that the Sapien transcatheter heart valve (Edwards Lifesciences) is a feasible option for patients with severe aortic stenosis deemed to be at high risk for open-heart surgery, though valve leakage was more common with the f...

Medtronic, CoreValve, Japan, approval, trial
Medtronic announced Japanese regulatory approval for the self-expanding transcatheter CoreValve system for patients with severe aortic stenosis (AS)....
Corevalve, VIV, valve in valve, FDA
The U.S. Food and Drug Administration (FDA) expanded the approved use of the CoreValve self-expanding transcatheter aortic valve replacement (TAVR) system to...
Edwards Lifesciences Corp. announced that chairman and CEO Michael A. Mussallem served as an invited expert panelist on behalf of the Advanced Medical...
TAVR, transcatheter heart valves, GlobalData, TMVR
Research and consulting firm GlobalData reported that the global market value for transcatheter heart valves will expand at a Compound Annual Growth Rate (CAGR...
Corevalve, VIV, valve in valve, FDA
The CoreValve self-expanding transcatheter aortic valve replacement (TAVR) system is now cleared for an additional indication to treat
The CAAS A-Valve from Pie Medical Imaging BV is the first 510(k)-cleared image analysis technology to determine aortic regurgitation based...
Medtronic’s Melody Transcatheter Pulmonary Valve (TPV) and its Ensemble Transcatheter Valve Delivery System are indicated for patients born...

Articles

Corevalve, VIV, valve in valve, FDA
The U.S. Food and Drug Administration (FDA) expanded the approved use of the CoreValve self-expanding transcatheter aortic valve replacement (TAVR) system to...
TAVR, transcatheter heart valves, GlobalData, TMVR
Research and consulting firm GlobalData reported that the global market value for transcatheter heart valves will expand at a Compound Annual Growth Rate (CAGR...
Edwards Lifesciences, Sapien 3, Partner, ACC.15, acc 2015
he Sapien 3 heart valve (Edwards Lifesciences) demonstrated lower death, stroke and paravalvular leak rates than earlier generation devices in patients at high...
Mitralign, transcatheter triscupid repair, TTVR, TR, first in human
A detailed reporting of the first successful case of a direct transcatheter tricuspid repair (TTVR) for severe TR has been reported by Prof. J. Schofer, M.D.,...

Video Center

The biggest technology news coming out of the 2015 American College of Cardiology (ACC) annual...
3 weeks 2 days ago
It’s been no secret that the American healthcare system needed to change to survive economically...
9 weeks 2 days ago
The silence is deafening. And since radiology associations, physician groups and vendors have yet...
11 weeks 2 days ago
Centricity, webinar, ZFV, ZFP, viewer, remote viewing system, enterprise
Healthcare organizations are demanding more capabilities for image viewers accessed by clinicians. Zero footprint (ZFP) viewers provide imaging tools from...
The webinar "State of the Art in MRI Pediatric Brain Perfusion Imaging" educates participants about the state of the art clinical and emerging translational...
This webinar discusses why contemporary adult cardiac interventions require significant ionizing radiation with potential health risks to both the patient and...